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T cells with suppressive properties were de-
scribed for the first time more than 30 yr ago 
and experienced an overwhelming renaissance 
in the last 10 yr (1, 2). Although diff  erent kinds 
of induced regulatory T cells (T reg cells) were 
described, it is common sense that naturally oc-
curring T reg cells are of capital importance for 
preventing autoimmunity (3). Basic research and 
preclinical studies revealed that they do not only 
play a crucial role in the maintenance of periph-
eral tolerance but also in the control of allergic, 
autoimmune, and infectious diseases and anti-
tumor responses as well (3). Today it is widely 
accepted that naturally occurring T reg cells 
  exert their regulatory capacity via cell contact–
dependent, cytokine–independent mechanisms. 
For instance, the use of T cells, defective in 
TGF-β signaling, or the application of neutraliz-
ing antibodies to TGF-β and IL-10 had no eff  ect 
on suppressor function in vitro (4). In addition, 
the use of TGF-β–defi  cient naturally occurring 
T reg cells in a T cell transfer colitis model or the 
adoptive transfer of naturally occurring  T reg cells 
from IL-10–defi  cient mice in an asthma model 
doubtlessly revealed that these immune sup-
pressive cytokines are not   directly involved in 
naturally occurring T reg cell–mediated sup-
pression in vivo (5, 6).
The inhibition of IL-2 gene expression in 
the responder T cells is a characteristic feature 
of naturally occurring T reg cell–mediated sup-
pression (7). However, the underlying molec-
ular mechanisms of this process still remain 
to be discovered (3). The fi  rst description of a 
physiological role of cAMP in 1957 gave rise to 
a brilliant concept of cAMP being a second 
messenger that mediates the eff  ects of a variety 
of diff  erent biologically active agents (8, 9). 
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Naturally occurring regulatory T cells (T reg cells) are a thymus-derived subset of T cells, 
which are crucial for the maintenance of peripheral tolerance by controlling potentially 
autoreactive T cells. However, the underlying molecular mechanisms of this strictly cell 
contact–dependent process are still elusive. Here we show that naturally occurring T reg 
cells harbor high levels of cyclic adenosine monophosphate (cAMP). This second messenger 
is known to be a potent inhibitor of proliferation and interleukin 2 synthesis in T cells. 
Upon coactivation with naturally occurring T reg cells the cAMP content of responder 
T cells is also strongly increased. Furthermore, we demonstrate that naturally occurring 
T reg cells and conventional T cells communicate via cell contact–dependent gap junction 
formation. The suppressive activity of naturally occurring T reg cells is abolished by a cAMP 
antagonist as well as by a gap junction inhibitor, which blocks the cell contact–dependent 
transfer of cAMP to responder T cells. Accordingly, our results suggest that cAMP is crucial 
for naturally occurring T reg cell–mediated suppression and traverses membranes via gap 
junctions. Hence, naturally occurring T reg cells unexpectedly may control the immune 
regulatory network by a well-known mechanism based on the intercellular transport 
of cAMP via gap junctions.
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Among miscellaneous functions, cAMP is known to be a po-
tent inhibitor of T cell growth, diff  erentiation, and prolifera-
tion (10). However, the mechanisms by which cAMP exerts 
this suppressive function are largely undetermined. The fi  rst 
evidence that cAMP-dependent signal transduction directly 
attenuates the production of IL-2 in CD4+ T cells was re-
cently further corroborated by the fi  nding of a novel cAMP-
inducible transcriptional repressor termed inducible cAMP 
early repressor (ICER; references 11, 12). Collectively, a mul-
titude of studies using cAMP-elevating agents such as prosta-
glandin E2, cholera toxin, and forskolin clearly demonstrated 
that cAMP is a potent inhibitor of IL-2 production and sub-
sequent proliferation of CD4+ T cells.
In this study we show that naturally occurring T reg cells 
mediate their suppressive capacity by transferring cAMP into 
responder CD4+ T cells via gap junctions (GJs). This analysis 
reveals for the fi  rst time an unexpected role for a classical 
second messenger in combination with an ubiquitous system 
of intercellular communication in naturally occurring T reg 
cell–mediated suppression.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
Comparative analyses of naturally occurring T reg cells and 
conventional CD4+ T cells (CD4+ T cells) using gene array 
technology and quantitative RT-PCR revealed that the ex-
pression of the cAMP-cleaving enzyme phosphodiesterase 
3B (PDE3B) was strongly reduced in naturally occurring 
T reg cells (unpublished data). This fi  nding was in agreement 
with recently published data (13) and led us to suggest that 
naturally occurring T reg cells harbor high concentrations of 
cAMP that profoundly suppress the production of IL-2 in 
naturally occurring T reg cells, which is a characteristic feature 
of this T cell population (3).
Assessment of cAMP detected high concentrations of 
cAMP in naturally occurring T reg cells, whereas in CD4+ 
T cells this second messenger was scarce (Fig. 1 A, t = 0). This 
diff  erence further increased after activation of both T cell types 
(Fig. 1 A, t = 4–16 h). In contrast, 16 h upon co-culture with 
naturally occurring T reg cells, CD4+ T cells showed a sub-
stantial increase of cAMP (Fig. 1 A, triangle). The usage of 
MHC-disparate T cell populations and the additional staining 
of CD4+ T cells with CFSE allowed us to exclude a contami-
nation of the FACSorted CD4+ T cells with co-cultured natu-
rally occurring T reg cells (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20062129/DC1). Thus, these 
data suggested that high concentrations of endogenous cAMP 
are responsible for the anergic phenotype of naturally occur-
ring T reg cells. Furthermore, the vigorous rise of cAMP in the 
suppressed CD4+ T cells implied that the suppressive potency 
of naturally occurring T reg cells is also mediated by cAMP.
Similar to the suppressive eff  ects of naturally occurring 
T reg cells, dibutyryl-cAMP or the “cAMP-elevating agent” 
forskolin are also potent inhibitors of IL-2 expression and 
T cell proliferation (references 10, 14–18; Fig. S2, A–C, available 
at http://www.jem.org/cgi/content/full/jem.20062129/DC1). 
Furthermore, addition of IL-2 compensated for the anti-
proliferative potency of forskolin and naturally occurring T reg 
cells for CD4+ T cells (reference 19; Fig. S2 D). Besides the 
compensatory eff  ect of exogenous IL-2, co-stimulation via 
CD28 was shown to abrogate naturally occurring T reg cell–
mediated suppression (7). Interestingly, co-stimulation via 
CD28 was recently found to potentiate T cell responses by 
down-regulating cAMP levels via recruitment of PDE4 to 
lipid rafts (20). Thus, these observations suggested that natu-
rally occurring T reg cells and cAMP trigger comparable if 
not identical mechanisms in suppressed CD4+ T cells. There-
fore, the infl  uence of naturally occurring T reg cells and for-
skolin on cAMP levels and proliferation of CD4+ T cells was 
further analyzed. Fig. 1 B demonstrates that forskolin (1 μM) 
as well as the addition of naturally occurring T reg cells (1:1) 
increased the concentration of cAMP in CD4+ T cells to 
identical levels. Moreover, a simultaneous assessment of the 
proliferation revealed that forskolin and co-cultured naturally 
occurring T reg cells exhibited the same antiproliferative 
potency on CD4+ T cells (Fig. S2 C).
To further clarify the function of cAMP in naturally oc-
curring T reg cell–mediated suppression, cAMP activity was 
Figure 1.  Naturally occurring T reg cell–mediated suppression 
is accompanied by a strong increase of cAMP in the suppressed 
CD4+ T cells. (A) CFSE-labeled CD4+ T cells (CD4; ◆) and naturally occurring 
T reg cells (■) were stimulated alone or in co-culture with anti-CD3 mAb 
and A20 cells as accessory cells for 4, 8, and 16 h. At the indicated time 
points, the CD4+ T cells from the co-culture were reisolated using FACS-
based cell sorting (CD4 (+nTreg); ▲) to a purity >99%. The cytosolic 
cAMP concentration was assessed using a cAMP-specifi  c ELISA. One rep-
resentative result of two independent experiments is shown. (B) CD4+ 
T cells and naturally occurring T reg cells were activated as described in A. 
Alternatively, CD4+ T cells were stimulated in the presence of 1 μM for-
skolin. After 20 h of stimulation, cytosolic cAMP concentrations were 
measured. Shown are the means ± SD of three independent experiments 
each performed in triplicates.JEM VOL. 204, June 11, 2007  1305
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blocked in CD4+ T cells by a cAMP antagonist, termed Rp-
cAMPS (21). Notably, after blockade of cAMP, IL-2 mRNA 
expression of CD4+ T cells was not substantially altered 
(unpublished data). However, upon co-culture with naturally 
occurring T reg cells, the strong inhibitory activity of these 
cells on IL-2 production of co-cultured CD4+ T cells was 
neutralized in a concentration-dependent manner. A consid-
erable eff  ect could be observed at a ratio of 1:1 (Fig. 2 A) and 
inhibition was almost completely abrogated when the number 
of naturally occurring T reg cells was halved (1:0.5, Fig. 2 B). 
In addition to the expression of IL-2, the suppressed prolifer-
ation of co-cultured CD4+ T cells can also be restored by 
Rp-cAMPS (Fig. S3, available at http://www.jem.org/cgi/
content/full/jem.20062129/DC1). Hence, these fi  ndings 
indicate that cAMP is essentially involved in naturally oc-
curring T reg cell–mediated suppression. Regarding the un-
derlying molecular mechanisms, it has been suggested that 
the transcriptional repressor ICER attenuates IL-2 expression 
by binding in competition to the transcription factor CREB 
(cAMP response element binding protein) to the IL-2 pro-
moter (10). Interestingly, we found that the expression of 
ICER in CD4+ T cells was enhanced upon co-culture with 
naturally occurring T reg cells (Fig. S4, calcein-high), indi-
cating that this transcriptional repressor is involved in naturally 
occurring T reg cell–mediated suppression most likely via 
cAMP (22).
Although diff  erent surface molecules like CTLA-4 and 
membrane-bound TGF-β were described to be involved, no 
satisfying explanation for the mechanisms of naturally occur-
ring T reg cell–mediated suppression has been put forward 
so far (4). Therefore, the question arose whether and how 
cAMP can be intercellularly transferred from naturally occur-
ring T reg cells to other T cells. With regard to this, GJs have 
been shown to transport cAMP very effi   ciently (23). GJs are 
build from connexins, a well-known family of membrane 
proteins that could play an as yet unexpected role in naturally 
occurring T reg cell–mediated suppression. Hence, accumu-
lation of cAMP in suppressed CD4+ T cells implied that it 
is directly transmitted from naturally occurring T reg cells to 
suppressed CD4+ T cells via GJ intercellular communication 
(GJIC). Both naturally occurring T reg cells as well as CD4+ 
T cells express several members of the connexin family that 
will allow GJIC (Table S1, available at http://www.jem.org/
cgi/content/full/jem.20062129/DC1).
To pursue this model, we used the permeant dye calcein 
that spreads from donor to recipient cells only via GJ (24). 
RAG-2–defi  cient, CD90.2-positive OT-II mice that contain 
CD4+ T cells, which express a transgenic T cell receptor rec-
ognizing OVA323-339 but lacking naturally occurring T reg 
cells, were immunized with OVA323-339 in CFA in the left 
hind footpad. 6 h later, preactivated congenic calcein-loaded 
naturally occurring T reg cells expressing CD90.1 and the 
same transgenic T cell receptor (OVA323-339) were adoptively 
transferred. After 24 h, draining and non-draining LNs were 
prepared and the host CD4+ T cell population was analyzed 
by FACS staining. CD4+ T cells isolated from the draining 
LN of immunized mice that were not treated with calcein-
loaded naturally occurring T reg cells served as control (Fig. 
3 A, left). A substantial part of the CD4+, CD90.1-negative 
T cells from the draining LNs of immunized mice that re-
ceived calcein-loaded naturally occurring T reg cells exhib-
ited a strong calcein staining (Fig. 3 A, middle, green). The 
transferred naturally occurring T reg cells can be identifi  ed in 
this blot as CD90.1-positive cells with high calcein staining 
(Fig. 3 A, middle, black). In contrast, CD4+, CD90.1-negative 
T cells from the nondraining LNs prepared from the same 
mouse did not exhibit any calcein staining, although comparable 
numbers of transferred naturally occurring T reg cells could 
also be detected in these LNs (Fig. 3 A, right, black population 
in top right).
Obviously, only activated CD4+ T cells are qualifi  ed to 
interact with naturally occurring T reg cells by GJIC, sug-
gesting that additional activation-induced surface molecules 
are required to enable GJIC. According to this, FACS ana-
lyses of the early activation marker CD69 revealed that al-
most all CD4+ T cells from the draining LNs of the control 
mice were activated in the absence of naturally occurring T 
reg cells (Fig. 3 B, left). In mice that received naturally oc-
curring T reg cells, the CD4+ host T cells that did not con-
tain calcein also exhibited a high expression of CD69 (Fig. 
3 B, middle). In contrast, the expression of CD69 was strongly 
reduced in the host CD4+ T cells, which received calcein 
from naturally occurring T reg cells, indicating that cell 
contact is also in vivo required for naturally occurring T reg 
cell–mediated inhibition by GJIC (Fig. 3 B, middle, green). 
CD4+ T cells from the nondraining LNs did not express 
CD69 (Fig. 3 B, right). Hence, these fi  ndings demonstrate 
that only the activation of CD4+ T cells that had received 
calcein upon contact with the transferred naturally occurring 
T reg cells was substantially suppressed. Therefore, these 
data indicate that in vivo a close cell contact and GJIC are 
Figure 2.  cAMP is a key component of naturally occurring T reg 
cell–mediated suppression. CD4+ T cells were preincubated for 30 min 
either with the specifi  c cAMP antagonist Rp-cAMPS or its solvent as de-
scribed in Materials and methods. Upon preincubation, cells were washed 
and activated separately (CD4) or in co-culture with naturally occurring 
T reg cells (CD4 +nTreg) at the indicated ratios. After 20 h of stimulation 
quantitative RT-PCR for the expression of IL-2 mRNA was performed 
and data were normalized according to the expression of EF1α mRNA 
and expressed as a percentage of IL-2 mRNA by setting the relative IL-2 
mRNA expression of the CD4 single culture to 100%. One representative 
assay performed in triplicates ± SD is shown.1306  cAMP IS CRUCIAL FOR REGULATORY T CELL–MEDIATED SUPPRESSION | Bopp et al.
necessary for naturally occurring T reg cell–mediated sup-
pressive activities, whereas soluble mediators like IL-10 or 
TGF-β do not seem to be directly involved. This assump-
tion is corroborated by publications showing that IL-10– 
or TGF-β–defi  cient, naturally occurring T reg cells were 
functionally not compromised in vitro and in vivo (4–6). 
Because calcein does not infl  uence the activation of CD4+ 
T cells (IL-2 production and proliferation; unpublished data) 
Figure 3.  Naturally occurring T reg cells and conventional CD4+ 
T cells communicate via GJ in vivo and in vitro. (A) OT-II, CD90.2-
positive, RAG-2–defi  cient mice were immunized subcutaneously with 
OVA323-339 in the left hind footpad. 6 h later vehicle or calcein-loaded 
naturally occurring T reg cells isolated from the spleens of CD90.1-positive 
congenic OT-II mice and preactivated for 48 h in vitro were injected 
i.v. 24 h after immunization, the draining and the nondraining LNs were 
dissected and LN cells were stained for the expression of CD4, CD69, and 
CD90.1. The intracellular calcein-level (A) and the expression of CD69 (B) 
were analyzed by gating on propidium iodide–negative and CD4+ LN cells. 
(C) CD4+ T cells from BALB/c mice (H2-Kd) were stimulated in vitro in the 
absence (single-culture; blue) or presence of calcein-loaded naturally 
occurring T reg cells isolated from the spleens of C57BL/6 (H2-Kb). 
After 20 h, cells were stained with an anti–H2-Kb mAb and GJIC was 
  assessed by analyzing calcein transfer (red, calcein-low; green, calcein-high). 
(D and E) Simultaneously, CD4+ T cells from the single culture and H2-Kb-
negative, calcein-high (green) or calcein-low (red) CD4+ T cells were 
reisolated from the co-cultures using FACS-based cell sorting and analyzed 
for their cytosolic cAMP concentration and the expression of IL-2 mRNA. 
(C–E) One representative result of three independent experiments. 
(F) Conventional CD90.1-positive CD4+ T cells were stimulated in the 
presence of CD90.2-positive naturally occurring T reg cells or CD90.2-
positive naturally occurring T reg cells that had been transfected with 
Alexa Fluor 488 cAMP. After 20 h, cells were stained for expression of 
CD90.1 to discriminate CD4+ T cells and T reg cells and analyzed for the 
diffusion of Alexa Fluor 488 cAMP to CD90.1-positive CD4+ T cells.JEM VOL. 204, June 11, 2007  1307
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these fi  ndings support our model that naturally occurring 
T reg cell–mediated suppression is mediated by cAMP trans-
ferred via GJIC.
To analyze this assumption in more detail, CD4+ T cells 
and calcein-loaded naturally occurring T reg cells were 
coactivated in vitro. Upon co-culture, CD4+ T cells that 
received high amounts of calcein from naturally occurring 
T reg cells (Fig. 3 C, green) and CD4+ T cells that con-
tained no or low amounts of calcein (Fig. 3 C, red) were 
FACSorted and the cAMP content of both populations was 
compared. Fig. 3 D illustrates that calcein-high CD4+ T cells 
harbor high concentrations of cAMP (green bar), whereas 
calcein-low CD4+ T cells harbor only low concentrations of 
cAMP (red bar) slightly higher than CD4+ T cells that had 
been activated in the absence of naturally occurring T reg 
cells (blue bar). The assessment of IL-2 expression revealed 
that calcein-high CD4+ T cells that harbor high amounts of 
cAMP express very low levels of IL-2 (Fig. 3 E, green bar), 
whereas calcein-low CD4+ T cells that harbor low amounts 
of cAMP express comparatively high levels of IL-2 (Fig. 3 E, 
red bar). This oppositional behavior of cAMP content and 
IL-2 expression clearly indicates that an elevated level of 
cAMP leads to the inhibition of IL-2 expression. CD4+ 
T cells activated in the absence of naturally occurring T reg 
cells expressed even more IL-2 (Fig. 3 E, blue bar) compared 
with calcein-low CD4+ T cells from the co-culture. This 
fi  nding can be explained by a fl  oating transition between the 
calcein-high and -low fraction of co-cultured CD4+ T cells 
resulting in a reduced IL-2 expression corresponding to a 
slightly increased cAMP content of the calcein-low CD4+ 
T cell population. To rule out an additional endogenous 
production of cAMP in suppressed CD4+ T cells by adenyl-
ate cyclases (ADCYs), experiments using ADCY inhibitors 
were conducted. Unfortunately, all commercially available 
ADCY inhibitors were toxic for freshly isolated mouse 
T cells preventing us from using such reagents to solve this 
question. Therefore, a contributing activation of endoge-
nous ADCYs in suppressed CD4+ T cells cannot be com-
pletely excluded. However, because it was published that 
GJs are permeable for Alexa dyes (25), we used Alexa 
Fluor 488 cAMP to demonstrate a direct transfer of cAMP 
via GJIC (Fig. 3 F). The transfer rate was comparatively low, 
obviously because Alexa Fluor 488 cAMP is considerably 
larger than cAMP, which strongly implies that cAMP alone 
can much better trespass the cell membrane. Experiments 
with calcein-stained and nonstained CD4+ T cells also re-
vealed a GJIC among CD4+ T cells (unpublished data). Be-
cause CD4+ T cells contain only minimal concentrations of 
cAMP the observed GJIC did not lead to any suppression. In 
addition, it should be noted that separation of naturally oc-
curring T reg cells and CD4+ T cells by transwell cultures 
not only abrogated naturally occurring T reg cell–mediated 
suppression but also completely prevented the transfer of 
calcein (unpublished data). This underscores the cell contact–
dependent mechanism of calcein and cAMP transfer via GJ 
between both cell types.
To further corroborate the participation of GJ in cAMP 
transport, GJIC should be disrupted. PCR analyses revealed 
that naturally occurring T reg cells and CD4+ T cells ex-
pressed connexin 31.1 (Cx31.1), Cx32, Cx43, Cx45, and Cx46 
(Table S1). These connexins can form homo- or heteromeric 
hexameric hemichannels (connexons), which align in neigh-
boring cells and build up homo- and heterotypic GJ during 
cell contact (26). This multitude of diff  erent GJ required a 
general inhibitor of GJIC. Unfortunately, substances like 18β-
glycyrrhetinic acid were highly toxic for T cells (unpublished 
data) or were shown to have other disadvantages like non-
specifi  c side eff  ects and a large size, which can limit their access, 
especially to the intercellular region of the GJ (27). In contrast, 
synthetic peptides that mimic connexins have been described 
to interfere with GJIC. GAP27 was especially described to be 
a potential GJ inhibitory peptide (27). This peptide is identical 
in sequence to a portion of an extracellular loop of Cx43 and 
interferes with both GJ formation and stability. The addition 
of GAP27 to co-cultures reduced the transfer of calcein to 
 50%, whereas a scrambled control peptide (SC-GAP27) did 
not have any eff  ect (Fig. 4 A). Simultaneously, the suppression 
of IL-2 mRNA expression in CD4+ T cells upon contact with 
naturally occurring T reg cells was substantially abrogated by 
the addition of GAP27, whereas SC-GAP27 had no eff  ect 
(Fig. 4 B). It was not possible to completely block the transfer 
of calcein, mostly because GAP27 could not inhibit all potential 
GJ variants with the same effi   ciency (27).
In conclusion, these data indicate that naturally occurring 
T reg cells mediate their suppressive capacity by transferring 
cAMP into responder cells via GJIC. Our analyses uncovered 
a new and exciting function for a classical second messenger 
in combination with an ubiquitous system of intercellular 
communication. The in vivo relevance of these fi  ndings can 
Figure 4.  Blocking GJIC simultaneously reduces the infl  ux of cal-
cein and the inhibition of IL-2 expression in CD4+ T cells upon 
  contact with naturally occurring T reg cells. (A) CD4+ T cells from 
BALB/c mice (H2-Kd) were activated separately (CD4) or in co-culture with 
calcein-loaded naturally occurring T reg cells (CD4 +nTreg) from C57BL/6 
mice (H2-Kb). As depicted, the cells were stimulated in the presence or 
absence of the GJ mimetic peptide GAP27 or a scrambled control peptide 
SC-GAP27, consisting of the same amino acids in a different order. 20 h 
upon stimulation, the calcein transfer was assessed by gating on CD4+ 
T cells (H2-Kb negative, propidium iodide negative). (B) In parallel, the CD4+ 
T cells were reisolated from the co-culture using FACS-based cell sorting 
to a purity >99%. Expression of IL-2 mRNA was assessed in triplicates by 
quantitative RT-PCR and data were normalized according to the expres-
sion of EF1α mRNA. Shown are the means ± SD of three independent 
experiments. N.d., not detectable.1308  cAMP IS CRUCIAL FOR REGULATORY T CELL–MEDIATED SUPPRESSION | Bopp et al.
be deduced from preclinical studies demonstrating that cAMP-
elevating agents like vasoactive intestinal peptide or PDE 
  inhibitors like pentoxifylline can alleviate autoimmune diseases 
via the increase of cAMP in self-reactive effector T cells 
(28, 29). Thus, the mechanism of action of such agents could 
be at least partially explained by their infl  uence on naturally 
occurring T reg cell–mediated suppression.
MATERIALS AND METHODS
Mice. Mice of strains BALB/c and C57BL/6 were obtained from Charles 
River Laboratories and bred in our own animal facility. OT-II mice, trans-
genic for the OVA323–339-specifi  c TCR-αβ (30), and RAG2-defi  cient mice 
(RAG−/−) were obtained from Charles River Laboratories and bred in our 
own animal facility. OT-II RAG−/− mice were obtained by intercrossing 
these lines accordingly. Males and females were used at 6–8 wk of age. All 
mice used for this study were bred and housed in a specifi  c pathogen-free 
colony at the animal facility of Johannes Gutenberg University using institu-
tionally approved protocols (permission was obtained from the Landesunter-
suchungsamt Koblenz).
Cytokines, antibodies, and reagents. Hybridoma cells producing anti-
CD4 mAb GK1.5 were obtained from American Type Culture Collection. 
PE-labeled rat anti-CD25 (7D4), PE-labeled anti-H2-Kb mAb (AF6-88.5), 
PE-Cy7–labeled hamster anti-CD69 (H1.2F3), and all corresponding isotypes 
were purchased from BD Biosciences. IL-2–specifi  c ELISA was performed 
using anti–mIL-2 (JES6-1A12) and biotinylated anti–mIL-2 (JES6-5H4; both 
from BD Biosciences). In addition, the following mAbs were used: anti-CD3 
mAb 145-2C11 and anti-CD28 mAb 37.51. If required, mAbs were affi   nity 
purifi  ed using protein G–Sepharose (GE Healthcare) and coupled with FITC 
or biotin. Mouse recombinant IL-2 was affi   nity purifi  ed using an anti–IL-2 
mAb bound to sepharose. Mitomycin C and forskolin were purchased from 
Sigma-Aldrich. 5-(and-6)-carboxyfl  uorescein diacetate, succinimidyl ester 
(5(6)-CFDASE; CFSE) and calcein AM were purchased from Invitrogen. CF-
DASE was dissolved in DMSO and calcein AM was dissolved in 100% ethanol. 
The connexin mimetic peptide GAP27 (S  R  P  T  E  K  T  I  F  I  I  ) and a control-peptide 
consistent with the same amino acids but with a randomly shuffl   ed sequence 
were synthesized and HPLC purifi  ed by Peptide Specialty Laboratories to a 
purity >98%. Peptides were dissolved in DMSO and added to cell cultures. 
Adenosine 3′,5′-cyclic monophosphorothioate, Rp-isomer,   triethylammonium 
salt (Rp-cAMPS) was purchased from Calbiochem and dissolved in aqua ad 
injectabilia. Alexa Fluor 488 cAMP was purchased from Invitrogen.
Cytokine assays. Cytokines were assayed by specifi  c two-site ELISA with 
reference standard curves using known amounts of the respective cytokine. For 
the detection of cytokines, we used the following combinations of mAbs: IL-2 
JES6-1A12 and biotinylated JES6-5H4.
Preparation of T cell populations. Conventional CD4+CD25− T cells 
(CD4+ T cells; GK1.5-FITC) and naturally occurring CD4+CD25+ T reg 
cells (7D4-PE) were isolated as described previously (31). Preactivation of 
naturally occurring T reg cells was performed using a combination of plate-
bound anti-CD3 mAb (145-2C11; 3 μg/ml) and anti-CD28 mAb (37.51; 
10 μg/ml). After 48 h the cells were harvested and used as preactivated natu-
rally occurring T reg cells.
FACS-based cell sort. CD4+ T cells were stained with CFDASE as de-
scribed previously (31). After co-culture, CFSE-labeled CD4+ T cells were 
washed in PBS containing 4% FCS and isolated using a cell sorter (FACS-
vantage SE and CellQuest Pro; BD Biosciences), with exclusion of dead cells 
by propidium iodide incorporation. The purity of the sorted cells was typically 
>99% (see Fig. S2).
T cell stimulation and proliferation assays. The T cell stimulation and 
proliferation assays were performed as described previously (31).
Polyclonal T cell activation. CD4+ T cells (106/ml) from BALB/c mice 
were activated in the presence of mitomycin C–treated (60 μg/ml/107 cells, 
30 min) A20 B tumor cells (105/ml) and soluble anti-CD3 mAb (3 μg/ml) 
in the absence or presence of naturally occurring T reg cells (106/ml) from 
BALB/c mice or C57BL/6 mice. To elevate the intracellular cAMP con-
centration, forskolin was added as indicated.
Transfection of naturally occurring T reg cells. Naturally occurring 
T reg cells (2 × 106 naturally occurring T reg cells/cuvette) were transfected 
with 240 μM Alexa Fluor 488 cAMP according to the instructions of the 
manufacturer (AMAXA). Cells were allowed to recover in medium for 2 h. 
5 × 105 CD90.2 naturally occurring T reg cells were co-cultured with 5 × 
105 CD90.1 CD4+ T cells in a 96-well round-bottom plate and stimulated 
for 20 h as described previously (31). Cells were washed with PBS and im-
munostaining was performed using anti–CD90.1-APC antibody and ana-
lyzed on a FACS Canto (BD Biosciences).
Blocking GJIC with the connexin mimetic peptide GAP27. CD4+ 
T cells from BALB/c mice were stained with CFSE, activated in single or 
co-culture with naturally occurring T reg cells from C57BL/6 mice in the 
presence or absence of 300 μM GAP27 or SC-GAP27, respectively. 20 h 
upon stimulation, the CD4+ T cells were reisolated using FACS-based cell 
sorting and lysed in Trizol (Invitrogen) to isolate total RNA.
Rp-cAMPS. To evaluate the role of cAMP in naturally occurring T reg 
cell–mediated suppression, CD4+ T cells were preincubated with varying 
amounts of Rp-cAMPS for 30 min, washed three times, and stimulated 
solely or in co-culture with naturally occurring T reg cells (1:1 and 1:0.5). 
After 20 h of stimulation total RNA was prepared and quantitative RT-PCR 
for the detection of IL-2 mRNA was performed.
cAMP ELISA. To assess cytosolic cAMP concentrations, T cells were 
washed three times in ice-cold PBS, lysed in 0.1 N HCl (107/ml) and a 
cAMP-specifi  c ELISA (Correlate EIA Direct Cyclic AMP Enzyme Immuno-
assay kit; Assay Design) was performed.
Calcein AM staining and GJIC detection in vitro. Naturally occurring 
T reg cells (107/ml) were incubated with 1 μM calcein AM in IMDM at 
37°C in 5% CO2 for 30 min. The cells were then washed three times with 
IMDM and stimulated as described above in a 48-well plate in co-culture 
(2 × 106 naturally occurring T reg cells + 2 × 106 conventional CD4+ T cells; 
ratio 1:1) for 20 h. Calcein transfer was detected on a FACS Canto.
Assessment of GJIC in vivo. OT-II, RAG-2–defi  cient, CD90.2-positive 
mice were immunized by injecting 50 μg OVA323-339 in CFA subcutane-
ously into the left hind footpad. 6 h later, 8 × 106 polyclonally preactivated, 
calcein-loaded, naturally occurring T reg cells from OT-II, CD90.1-positive 
mice were injected i.v. into the OVA323-339-immunized OT-II, RAG-2–
  defi  cient, CD90.2-positive mice. 24 h upon immunization the draining and 
the nondraining popliteal LNs were removed and LN cells were stained for 
the expression of CD4, CD90.1, and CD69. By gating on propidium iodide–
negative CD4+ LN cells calcein transfer, the expression of CD90.1 (naturally 
occurring T reg cells) and the early activation marker CD69 were analyzed 
using a FACS Canto.
mRNA detection. RNA was isolated using Trizol and cDNA was synthe-
sized with RevertAid M-MuLV reverse transcriptase following the recom-
mendations of the supplier (MBI Fermentas). Quantitative RT-PCRs were 
performed using the following oligonucleotides:
IL-2 forward, CCT GAG CAG GAT GGA GAA TTA CAG G; IL-2 re-
verse, GCA CTC AAA TGT GTT GTC AGA GCC C; elongation factor-1 α 
(EF1α) forward, GAT TAC AGG GAC ATC TCA GGC TG; EF1α reverse, 
TAT CTC TTC TGG CTG TAG GGT GG; Cx26 forward, CAA CGC 
TGC ACG CTC CTC CC; Cx26 reverse, GCC AGG CTG GAG CGT 
GTT GC; Cx30 forward, TGC AGT GAC TCT TGA GCT GG; Cx30 JEM VOL. 204, June 11, 2007  1309
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reverse, CAT GTC TGT AGT AGG CCA CG; Cx30.3 forward, GAC CCA 
AGA AGG AAG GAA AG; Cx30.3 reverse, CTC ATC ATA GCA GAC 
CTT GG; Cx31 forward, TCG TTC CTC CTC TGC TGT GG; Cx31 re-
verse, TCG GCA GCC ACC ACA TAC AC; Cx31.1 forward, CCA AGC 
CCT CCG AGA AAA AC; Cx31.1 reverse, TCC GAG CCC AGA AAG 
ATG AG; Cx32 forward, GAA GAG GTA AAG AGA CAC AAG G; Cx32 
reverse, ACG TTG AGG ATA ATG CAG ATG; Cx37 forward, AGA GAG 
GCC CTG GAA ACA TG; Cx37 reverse, CAT AGC AGA CGT TGG TGC 
AG; Cx40 forward, AGA GCC TGA AGA AGC CAA C; Cx40 reverse, AAC 
AGG ACA GTG AGC CAG AC; Cx43 forward, TAC CAC GCC ACC 
ACT GGC; Cx43   reverse, AAT CTC CAG GTC ATC AGG; Cx45 forward, 
AAA GAG CAG AGC CAA CCA AA; Cx45 reverse, GTC CCA AAC CCT 
AAG TGA AGC; Cx46 forward, GGA AAG GCC ACA GGG TTT CCT 
GG; Cx46 reverse, GGG TCC AGG AGG ACC AAC GG; Cx50 forward, 
AAG ACA GCA CCA GTT TCT CC; Cx50 reverse, GAC AGT GGA GTG 
CTC ATT CA; ICER forward, ATG GCT GTA ACT GGA GAT GAA; 
ICER   reverse, AGC AAA TGT CTT TCA AAC TTT CAA.
Oligonucleotides were chosen to span at least one intron at the level of 
genomic DNA. Quantitative RT-PCR analyses to quantify the expression 
of IL-2, the indicated connexins, and EF1α mRNAs were performed in 
triplicates on an iCycler (Bio-Rad Laboratories) using the IQ SYBR Green 
Supermix (Bio-Rad Laboratories). After normalization of the data according 
to the expression of EF1α mRNA, the relative expression levels of IL-2 and 
connexin mRNAs were calculated.
Online supplemental material. Fig. S1 shows the purity of FACSorted 
CD4+ T cells upon co-culture with naturally occurring T reg cells. Fig. S2 
shows that naturally occurring T reg cells and the cAMP-elevating agent 
forskolin comparatively aff  ect IL-2 gene expression and IL-2 production 
of CD4+ T cells. Fig. S3 shows the abrogation of naturally occurring T reg 
cell–mediated suppression of proliferation by the addition of the cAMP an-
tagonist Rp-cAMPS. Fig. S4 shows the elevation of ICER mRNA expres-
sion in CD4+ T cells upon co-culture with naturally occurring T reg cells. 
Table S1 summarizes the connexin genes expressed by CD4+ T cells and 
naturally occurring T reg cells. The online supplemental material is available 
at http://www.jem.org/cgi/content/full/jem.20062129/DC1.
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